Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

NCT06956482 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT06956482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Lead sponsor
University Hospital, Lille
Phase
Phase 3
Overall status
Recruiting
Start date
May 22, 2026
Completion date
May 31, 2030
Enrollment
477 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis